BPC-157 Acetate vs. Arginate
The Bottom Line:
Same peptide sequence (GEPPPGKPADDAGLV). The only difference? The salt counterion.
Acetate – conventional, widely studied form
Arginate – paired with arginine instead of acetate
What's Not Different:
  • The active peptide is identical
  • No peer-reviewed studies show efficacy differences
  • Stability claims (e.g., "1,000x more stable") are unverified vendor claims, not published science.
Why Arginate Exists:
After FDA restricted BPC-157, some vendors rebranded the arginate salt as "PDA" to argue it's a new chemical entity. Regulatory experts view this skeptically – the FDA targets the peptide sequence, not the salt.
Key Takeaway:
Same molecule. Different salt. No proven functional difference.
For research-grade BPC-157, check OrionPeptide.com – lab-verified quality.
0
0 comments
Alex Bennett
3
BPC-157 Acetate vs. Arginate
powered by
Orion Peptides
skool.com/biohacking-and-longevity-group-3757
All-in-one peptide education community. 🧪
Dosing guides, storage protocols, stacking frameworks, vendor intel, GLP-1 research, and expert support.🧬
Build your own community
Bring people together around your passion and get paid.
Powered by